Newmont Corp (NYSE:NEM) has seen recent insider activity from one of its high-level executives. David John Thornton, the Managing Director for the Americas, executed a sale of 2,296 shares of the company's common stock on May 1, 2026. This specific transaction was conducted at a price of $110.11 per share, resulting in total proceeds of $252,812. This sale was not an impromptu market move but was carried out under a Rule 10b5-1 trading plan that had been put in place on December 1, 2025.
Prior to this, another transaction occurred involving Mr. Thornton on April 30, 2026. On that date, he disposed of 1,805 shares of Newmont common stock at a price of $107.61 per share, totaling $194,236. This particular disposal was designated to satisfy tax withholding obligations stemming from the vesting of 4,101 stock-settled restricted stock units. Following these two separate actions, Mr. Thornton's direct holdings in Newmont Corp common stock stand at 23,163 shares.
Operational and Financial Context
These insider transactions take place while the company is navigating a period of strong financial results. In its first-quarter earnings report, Newmont exceeded market expectations on several key metrics. The company reported an earnings per share (EPS) of $2.90, which was 33.03% higher than the forecasted $2.18. Furthermore, revenue reached $7.31 billion, outperforming the anticipated $6.53 billion by an 11.94% margin.
The strength of the company's fundamentals was further highlighted by its EBITDA, which beat forecasts by 31%, and a record free cash flow of $3.1 billion. These results were attributed to stronger production levels and lower costs during the period. Current market data shows the stock trading at $108.33, following a one-year return of 114%.
Market Analyst Perspectives
Financial institutions have reacted positively to these operational developments. Canaccord Genuity maintained its Buy rating and set a price target of $150, citing the strength of the quarterly results. Similarly, BMO Capital adjusted its outlook, raising its price target for Newmont from $140 to $145 while maintaining an Outperform rating. This adjustment was prompted by both the first-quarter results and the company's year-to-date share buyback activity. Despite the recent insider sales, assessments suggest the stock may remain undervalued based on Fair Value metrics, supported by a financial health score categorized as "EXCELLENT."